3-WP
3-WP is a linear 20-peptide with a C-terminal amidation modification. 3-WP acts on lipoteichoic acid (LTA) and disrupts cell wall permeability, induces intracellular reactive oxygen species (ROS) accumulation in a dose-dependent manner, and simultaneously inhibits respiratory chain dehydrogenase activity and intracellular ATP synthesis, thereby interfering with bacterial energy metabolism and exerting Bacterial antibacterial effects. The combination of 3-WP and Melittin (HY-P0233) exerts synergistic antibacterial effects against Gram-positive bacteria, reduces the required dosage of Melittin, and thus improves the cell selectivity of Melittin. 3-WP can serve as a peptide adjuvant for Melittin in food storage scenarios. 3-WP can be used in the research of foodborne diseases caused by methicillin-resistant Staphylococcus aureus.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C135H183N41O20
- 分子量:2700.16
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
IC50 & Target
[1]|
MRSA ATCC43300 |
MRSA DL5F2 |
MRSA DN65 |
体外実験
3-WP (32 μM; 24 h) acts synergistically with Melittin to enhance the antibacterial activity against multiple Gram-positive strains including MRSA ATCC43300, MRSA DL5F2 and MRSA DN65, with FICI values ranging from 0.125 to 0.250. 3-WP significantly reduces the geometric mean MIC of melittin from 2.333 μM to 0.250 μM, indicating that 3-WP effectively enhances the antibacterial efficacy of melittin[1].
3-WP (1-64 μM; 4 h) exhibits favorable biosafety even at concentrations up to 64 μM, with no hemolysis or cytotoxicity; when used in combination with Melittin (HY-P0233), its cell selectivity is enhanced, and the SI against Gram-positive bacteria relative to mammalian cells increases to 53.827[1].
Combination treatment with 3-WP (1 μM; 24 h) and 0.125 μM Melittin exerts synergistic bactericidal activity against MRSA ATCC43300, reducing bacterial counts by nearly 5-log10 within 24 hours[1].
Combination of 3-WP (passaged for 30 generations) and Melittin delays the development of bacterial resistance in MRSA ATCC43300, with its MIC increasing only 2-fold after 30 consecutive passages[1].
Combination treatment with 3-WP (2 μM; 24 h) and 0.25 μM Melittin significantly inhibits biofilm formation of MRSA ATCC43300, reduces biofilm biomass and disrupts biofilm structure, whereas 3-WP used alone shows no such effects[1].
3-WP (2-8 μM) binds to LTA and disrupts the cell wall permeability of MRSA ATCC43300 in a dose-dependent manner, and this activity is retained when used in combination with 0.25 μM Melittin[1].
Combination treatment with 3-WP (2 μM; 0-120 min) and 0.25 μM Melittin significantly enhances cytoplasmic membrane damage to MRSA ATCC43300, increasing membrane rigidity, permeability, depolarization level and ATP leakage[1].
3-WP (2-8 μM; 0.5-4 h) induces dose-dependent accumulation of ROS in MRSA ATCC43300 and inhibits its energy metabolism (intracellular ATP production and respiratory chain dehydrogenase activity)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
化学情報
-
分子量 2700.16
-
分子式 C135H183N41O20
-
配列
Trp-Pro-Arg-Pro-Trp-Pro-Arg-Pro-Trp-Pro-Arg-Pro-Trp-Pro-Arg-Pro-Trp-Pro-Arg-Pro-NH2
-
シーケンスの短縮
WPRPWPRPWPRPWPRPWPRP-NH2
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
プロトコル
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Transepithelial/transendothelial electrical resistance assay
TEER measures electrical resistance across epithelial or endothelial monolayers cultured on permeable supports, and the readout reflects ionic conductance through the cell barrier, especially the paracellular pathway regulated by junctional integrity. TEER can be measured without destroying the monolayer and is commonly used before or during transport, permeability, barrier-disruption, and barrier-maturation experiments. TEER values are influenced by biological maturation and technical conditions; reported factors include temperature, medium formulation, passage number, electrode geometry, membrane properties, and junctional length during early monolayer maturation. Therefore, TEER should be interpreted with blank-insert subtraction, area normalization, repeated readings, and, when possible, orthogonal barrier readouts such as FITC-dextran flux or tight-junction staining.
-
Gram Staining of Tissue Sections
Gram staining of tissue sections is a histochemical technique used to differentiate Gram-positive and Gram-negative bacteria within histological specimens based on differences in bacterial cell wall structure and dye retention, adapted from classical bacteriological Gram staining into tissue-compatible “histological Gram stain” variants. In tissue applications, modifications of the Brown-Hopps and Brown-Brenn methods are commonly used to improve differentiation of microorganisms embedded within host connective tissue and to reduce overstaining or loss of Gram-negative signal, which are known limitations of earlier approaches. The principle relies on crystal violet-iodine complex retention in Gram-positive organisms and subsequent decolorization and counterstaining steps that allow contrast visualization of Gram-negative organisms against tissue background.
純度とドキュメンテーション
参考文献
[1]. HY-P11909.pdf
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)